| 54 |
Titel |
TI |
[EN] A CONJUGATE COMPLEX FACILITATING THE TRANSPORT OF A CARGO THROUGH A MEDIUM |
| 71/73 |
Anmelder/Inhaber |
PA |
BADEN WUERTTEMBERG STIFTUNG GMBH, DE
|
| 72 |
Erfinder |
IN |
BILL JOACHIM, DE
;
FISCHER PEER, DE
;
ROTHENSTEIN DIRK, DE
|
| 22/96 |
Anmeldedatum |
AD |
25.06.2018 |
| 21 |
Anmeldenummer |
AN |
201816624808 |
|
Anmeldeland |
AC |
US |
|
Veröffentlichungsdatum |
PUB |
09.07.2020 |
33
31
32 |
Priorität |
PRC
PRN
PRD |
EP
2018066893
25.06.2018
|
33
31
32 |
PRC
PRN
PRD |
EP
17001088
26.06.2017
|
| 51 |
IPC-Hauptklasse |
ICM |
A61K 47/69
(2017.01)
|
| 51 |
IPC-Nebenklasse |
ICS |
A61K 47/64
(2017.01)
C12N 7/00
(2006.01)
|
|
IPC-Zusatzklasse |
ICA |
|
|
IPC-Indexklasse |
ICI |
|
|
Gemeinsame Patentklassifikation |
CPC |
A61K 41/00
A61K 47/64
A61K 47/6901
A61K 47/6923
C12N 2795/14122
C12N 2795/14141
C12N 2795/14142
C12N 7/00
|
|
MCD-Hauptklasse |
MCM |
A61K 47/69
(2017.01)
|
|
MCD-Nebenklasse |
MCS |
A61K 47/64
(2017.01)
C12N 7/00
(2006.01)
|
|
MCD-Zusatzklasse |
MCA |
|
| 57 |
Zusammenfassung |
AB |
[EN] The present invention relates to conjugate complexes, comprising at least one biological entity, at least one cargo moiety, and at least one effector moiety that is capable of converting, degrading, and/or modifying a given medium, wherein the at least one cargo moiety and the at least one effector moiety are directly or indirectly coupled to the biological entity. The present invention further relates to uses thereof and methods for facilitating the transport of a cargo moiety through a given medium. |
| 56 |
Entgegengehaltene Patentdokumente/Zitate,
in Recherche ermittelt |
CT |
|
| 56 |
Entgegengehaltene Patentdokumente/Zitate,
vom Anmelder genannt |
CT |
|
| 56 |
Entgegengehaltene Nichtpatentliteratur/Zitate,
in Recherche ermittelt |
CTNP |
Celli et al. Helicobacter pylori moves through mucus by reducing mucin viscoelasticity. P.N.A.S., 2009, 106: 14321-14326. 0;
Garcia et al. Investigation of the binding and cleavage characteristics of N1 neuraminidases from avian, seasonal, and pandemic influenza viruses using saturation transfer difference nuclear magnetic resonance. Influenza Other Respir Viruses. 2014. Mar; 8(2): 235-42. Epub 2013 Sep 30. 0;
Ghosh et al. M13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer. Nature Nanotechnology. 2012, 7: 677-682. 0;
Liebana et al. Phagomagnetic Separation and Electrochemical Magneto-Genosensing of Pathogenic Bacteria. Anal. Chem. 2013, 85, 3079−3086. 0;
Nakagawa et al. Isolation and Characterization of the Bacteriophage T4 Tail-Associated Lysozyme. J Virol. 0;
Riva et al. The outer membrane protease PgtE of Salmonella enterica interferes with the alternative complement pathway by cleaving factors B and H. Front. Microbiol., 06 February 2015, pp 1-9. 0;
Tolba et al. Oriented Immobilization of Bacteriophages for Biosensor Applications. Appl Environ Microbiol. 2010 Jan; 76(2): 528–535. 0;
Westwater et al. Use of Genetically Engineered Phage To Deliver Antimicrobial Agents to Bacteria: an Alternative Therapy for Treatment of Bacterial Infections. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47(4): 1301–1307. 0
|
| 56 |
Entgegengehaltene Nichtpatentliteratur/Zitate,
vom Anmelder genannt |
CTNP |
|
|
Zitierende Dokumente |
|
Dokumente ermitteln
|
|
Sequenzprotokoll |
|
|
|
Prüfstoff-IPC |
ICP |
A61K 41/00
C12N 7/00
|
